Low-Grade Serous Ovarian Cancer (LGSOC) is recognized as a distinct form of ovarian cancer, different from High-Grade Serous Ovarian Cancer (HGSOC). This distinction, proven by researchers in 2004, was a crucial first step in understanding and effectively diagnosing and treating LGSOC. Early research highlighted hormone therapy and MEK inhibitors, typically used in other cancers, as potential treatments, paving the way for dedicated clinical trials and a deeper understanding of Lgsoc Diagnosis and management.
Posted inCardiagtech